Reimmunization after bone marrow transplantation - Current recommendations and perspectives

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 1, 2004, Pages 151-158

  Machado, C M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allogeneic; Autologous; Bone marrow transplantation; Polysaccharide; Toxoid; Vaccination

Indexed keywords

ANTIBODY CONJUGATE; CHICKENPOX VACCINE; DIPHTHERIA TOXOID; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS POLYSACCHARIDE; POLIOMYELITIS VACCINE; TETANUS TOXOID; VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL PROTOCOL; DRUG DOSE REGIMEN; EXPOSURE; HEALTH CENTER; HEALTH PROGRAM; HUMAN; IMMUNOLOGICAL MEMORY; INFECTION; LIFESPAN; REVACCINATION; REVIEW; SIDE EFFECT;

HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 1242352077     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000100021     Document Type: Review

References (41)

1. Lum LG (1987). The kinetics of immune reconstitution after human marrow transplantation. Blood, 69: 369-380.
2. Ljungman P, Fridell E, Lonnqvist B, Bolme P, Bottiger M, Gahrton G, Linde A, Ringden O & Wahren B (1989). Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. Journal of Infectious Diseases, 159: 610-615.
3. Ljungman P, Wiklund-Hammarsten M, Duraj V, Hammarstrom L, Lonnqvist B, Paulin T, Ringden O, Pepe MS & Gahrton G (1990). Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. Journal of Infectious Diseases, 162: 496-500.
4. Ljungman P, Duraj V & Magnius L (1991). Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplantation, 7: 89-93.
5. Machado CM, Gonçalves FB, Pannuti CS, Dulley FL & Souza VAUF (2002). Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil. Blood, 99: 83-67.
6. Ljungman P, Cordonnier C, De Bock R, Einsele H, Engelhard D, Grundy J, Link H, Locasciulli A, Prentice G & Reusser P (1995). Immunizations after bone marrow transplantation: results of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 15: 455-460.
7. Somani J & Larson RA (1995). Reimmunization after allogeneic bone marrow transplantation. American Journal of Medicine, 98: 389-398.
8. Henning KJ, Whilte MH, Sepkowitz KA & Armstrong D (1997). A national survey of immunization practices following allogeneic bone marrow transplantation. Journal of the American Medical Association, 277: 1148-1151.
9. Singhal S & Mehta J (1999). Reimmunization after blood or marrow stem cell transplantation. Bone Marrow Transplantation, 23: 637-646.
10. Dykewicz CA, Jaffe HW & Kaplan JE (2000). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Morbidity and Mortality Weekly Report, 49 (RR-10): 1-128.
11. Lum LG, Seigneuret MC & Storb R (1986). The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients. Journal of Clinical Immunology, 6: 389-396.
12. Parkkali T, Ruutu T, Stenvik M, Kuronen T, Kayhty H, Hovi T, Olander RM, Volin L & Ruutu P (1996). Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. Acta Pathologica, Microbiologica et Immunologica Scandinavica, 104: 383-388.
13. Li Volti S, Mauro L, Di Gregorio F, Romeo MA, Lupo L, Pizzarelli G, Mangiagli A, Giammanco G & Russo G (1994). Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplantation, 14: 225-227.
14. Parkkali T, Olander RM, Ruutu T, Vuontela K, Volin L, Eskola J & Ruutu P (1997). A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplantation, 19: 933-938.
15. Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA & Gale RP (1983). Pneumococcal vaccination of recipients of bone marrow transplants. Archives of Internal Medicine, 143: 1735-1737.
16. Lortan JE, Vellodi J, Jurges ES & Hugh-Jones K (1992). Class-and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clinical and Experimental Immunology, 88: 512-519.
17. Hammarstrom V, Pauksen K, Azinge J, Oberg G & Ljungman P (1993). Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction. Supportive Care in Cancer, 1: 195-199.
18. Parkkali T, Kayhty H, Ruutu T, Volin L, Eskola J & Ruutu P (1996). A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplantation, 18: 961-967.
19. Spoulou V, Victoratos P, Ioannidis JPA & Grafakos S (2000). Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. Journal of Infectious Diseases, 182: 965-969.
20. Molrine DC, Guinan EC, Antin JH et al. (1996). Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood, 87: 3012-3018.
21. Avanzini MA, Carra AM, Maccario R, Zecca M, Pignatti P, Marconi M, Comoli P, Bonetti F, De Stefano P & Locatelli F (1995). Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. Journal of Clinical Immunology, 15: 137-144.
22. Molrine DC, Antin JH, Guinan EC, Soiffer RJ, MacDonald K, Malley R, Malinoski F, Trocciola S, Wilson M & Ambrosino DM (2003). Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood, 101: 831-836.
23. Guinan EC, Molrine DC, Antin JH, Lee MC, Weinstein HJ, Sallan SE, Parsons SK, Wheeler C, Gross W & McGarigle C (1994). Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation, 57: 677-684.
24. Vance E, George S, Guinan EC, Wheeler C, Antin JH, Ambrosino DM & Molrine DC (1998). Comparison of multiple immunization schedules for Haemophilus influenzae type-b conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplantation, 22: 735-741.
25. Barra A, Cordonnier C, Preziosi MP, Intrator L, Hessel L, Fritzell B & Preud'homme JL (1992). Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. Journal of Infectious Diseases, 166: 1021-1028.
26. Engelhard D, Handsher R, Naparstek E, Hardan I, Strauss N, Aker M, Or R, Baciu H & Slavin S (1991). Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplantation, 8: 295-300.
27. Parkkarli T, Stenvik M, Ruutu T, Hovi T, Volin L & Ruutu P (1997). Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplantation, 20: 663-668.
28. Pauksen K, Duraj V, Ljungman P, Sjolin J, Oberg G, Lonnerholm G, Fridell E, Smedmyr B & Simonsson B (1992). Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplantation, 9: 427-432.
29. Nakano T, Shimono Y, Sugiyama K et al. (1996). Clinical features of measles in immunocompromised children. Acta Paediatrica Japonica, 38: 212-217.
30. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V, Aschan J, Brandt L, Bolme P, Lonnqvist B, Johansson N, Ringden O & Gahrton G (1994). Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood, 84: 657-663.
31. Ljungman P (1999). Immunization of transplant patients. Bone Marrow Transplantation, 23: 635-636.
32. Machado CM, Sumita LM, Rocha IF, Pannuti CS & Souza VAUF (2002). Early measles vaccination in BMT recipients. The 12th International Symposium on Infections in the Immunocompromised Host. Bergen, Norway, June 23-26, 2002.
33. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, Strauss N, Parag G, Naparstek E & Ravid Z (1993). Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-deplated and autologous BMT recipients. Bone Marrow Transplantation, 11: 1-5.
34. Pauksen K, Linde A, Hammarstrom V, Sjolin J, Carneskog J, Jonsson G, Oberg G, Engelmann H & Ljungman P (2000). Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clinical Infectious Diseases, 30: 342-348.
35. Sauerberi A, Prager J, Hengst U, Zintl F & Wutzler P (1997). Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplantation, 20: 381-383.
36. Redman RL, Nader S, Zerboni L, Liu C, Wong RM, Brown BW & Arvin AM (1997). Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. Journal of Infectious Diseases, 176: 578-585.
37. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K & Arvin AM (2002). Use of inactivated varicella vaccine in recipients of hematopoietic-cell transplants. New England Journal of Medicine, 347: 26-34.
38. Nagler A, Ilan Y, Adler R, Or R, Naparstek E, Shouval D & Slavin S (1995). Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Bone Marrow Transplantation, 15: 475-478.
39. Ilan Y, Nagler A, Adler R, Naparstek E, Or R, Slavin S, Brautbar C & Shouval D (1993). Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology, 18: 246-252.
40. Machado CM, Rocha IF, Diomede B et al. (1996). Effectiveness of hepatitis B vaccination and persistence of immunity after BMT (Abstract). The Ninth International Symposium on Infections in the Immunocompromised Host. Assisi, Italy, June 23-26, 1996.
41. Wilson ME (2001). Travel-related vaccines. Infectious Disease Clinics of North America, 15: 231-251.